Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Genentech announces positive clinical results for BTK inhibitor MS treatment

Multiple sclerosis affects more than 2.9 million people globally

- PMLiVE

Merck and Blackstone agree on funding for cancer protein antibody

The funding will support late-stage clinical development of the investigational antibody-drug conjugate

- PMLiVE

The hidden strength of teams: how collaboration can build resilience

True resilience is about creating an environment where teams can adapt and thrive

- PMLiVE

Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership

- New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of Uniphar Pharma...

Uniphar

- PMLiVE

Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk

The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer

- PMLiVE

LEO Pharma receives NICE approval for chronic hand eczema cream

The cream can now be prescribed for patients when topical corticosteroids have not worked or are not suitable

- PMLiVE

From disruption to resilience: India’s growing role in pharma logistics

In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever

- PMLiVE

Novo Nordisk agrees to lower certain drug prices in the US

The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid

- PMLiVE

Lilly announces agreement with US government to lower patient costs

The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels

- PMLiVE

Support your backbone with legacy brands that deliver competitive edge

Legacy assets may no longer be the star of the show, but they remain critical

Scientific researcher.Science students working with chemicals in the lab at the university.Happy student, content for experimental results.Pharmacy.Medicine

Branded or unbranded? The content strategy dilemma in clinical marketing

Branded or unbranded? In clinical marketing, this choice shapes how your message lands. Learn how to pick the right strategy for your goals, audience, and regulatory landscape.

Springer Nature

- PMLiVE

Boehringer Ingelheim and CDR-Life agree on deal worth up to $570m

The deal focuses on T cell-based therapies for autoimmune disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links